856P Safety of Neoadjuvant PARP Inhibitor and Immunotherapy in Locally Advanced HPV-negative Head and Neck Squamous Cell Carcinoma (PRIME H&N Study)
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined